BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 28127995)

  • 1. Targeting β-amyloid plaques and oligomers: development of near-IR fluorescence imaging probes.
    Liu H; Yang J; Wang L; Xu Y; Zhang S; Lv J; Ran C; Li Y
    Future Med Chem; 2017 Feb; 9(2):179-198. PubMed ID: 28127995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in fluorescent probes for detection and imaging of amyloid-β peptides in Alzheimer's disease.
    Zhang Y; Ding C; Li C; Wang X
    Adv Clin Chem; 2021; 103():135-190. PubMed ID: 34229849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Near-Infrared Fluorescent Probes for Use in Alzheimer's Disease Diagnosis.
    Yang J; Zeng F; Ge Y; Peng K; Li X; Li Y; Xu Y
    Bioconjug Chem; 2020 Jan; 31(1):2-15. PubMed ID: 31769660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in the study of near-infrared fluorescent probes for the detection of β-amyloid deposition in Alzheimer's disease].
    Du L; Feng HW; Li YY
    Yao Xue Xue Bao; 2015 May; 50(5):528-34. PubMed ID: 26234131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring the aggregation processes of amyloid-β using a spin-labeled, fluorescent nitroxyl radical.
    Mito F; Yamasaki T; Ito Y; Yamato M; Mino H; Sadasue H; Shirahama C; Sakai K; Utsumi H; Yamada K
    Chem Commun (Camb); 2011 May; 47(17):5070-2. PubMed ID: 21442105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence Chemicals To Detect Insoluble and Soluble Amyloid-β Aggregates.
    Lee D; Kim SM; Kim HY; Kim Y
    ACS Chem Neurosci; 2019 Jun; 10(6):2647-2657. PubMed ID: 31009195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in development of fluorescent probes for detecting amyloid-β aggregates.
    Xu MM; Ren WM; Tang XC; Hu YH; Zhang HY
    Acta Pharmacol Sin; 2016 Jun; 37(6):719-30. PubMed ID: 26997567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared fluorescence molecular imaging of amyloid beta species and monitoring therapy in animal models of Alzheimer's disease.
    Zhang X; Tian Y; Zhang C; Tian X; Ross AW; Moir RD; Sun H; Tanzi RE; Moore A; Ran C
    Proc Natl Acad Sci U S A; 2015 Aug; 112(31):9734-9. PubMed ID: 26199414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neutral merocyanine dyes: for in vivo NIR fluorescence imaging of amyloid-β plaques.
    Yan JW; Zhu JY; Zhou KX; Wang JS; Tan HY; Xu ZY; Chen SB; Lu YT; Cui MC; Zhang L
    Chem Commun (Camb); 2017 Aug; 53(71):9910-9913. PubMed ID: 28828456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescent Imaging of β-Amyloid Using BODIPY Based Near-Infrared Off-On Fluorescent Probe.
    Ren W; Zhang J; Peng C; Xiang H; Chen J; Peng C; Zhu W; Huang R; Zhang H; Hu Y
    Bioconjug Chem; 2018 Oct; 29(10):3459-3466. PubMed ID: 30189724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of Phenothiazine-Based Theranostic Compounds That Act Both as Inhibitors of β-Amyloid Aggregation and as Imaging Probes for Amyloid Plaques in Alzheimer's Disease.
    Dao P; Ye F; Liu Y; Du ZY; Zhang K; Dong CZ; Meunier B; Chen H
    ACS Chem Neurosci; 2017 Apr; 8(4):798-806. PubMed ID: 28097868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis and evaluation of curcumin-based fluorescent probes to detect Aβ fibrils.
    Sato T; Hotsumi M; Makabe K; Konno H
    Bioorg Med Chem Lett; 2018 Dec; 28(22):3520-3525. PubMed ID: 30297285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent Imaging of Amyloid-β Deposits in Brain: An Overview of Probe Development and a Highlight of the Applications for In Vivo Imaging.
    Fu H; Cui M
    Curr Med Chem; 2018; 25(23):2736-2759. PubMed ID: 29446721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid-β Deposits Target Efficient Near-Infrared Fluorescent Probes: Synthesis, in Vitro Evaluation, and in Vivo Imaging.
    Fu H; Tu P; Zhao L; Dai J; Liu B; Cui M
    Anal Chem; 2016 Feb; 88(3):1944-50. PubMed ID: 26717442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluorescent 2-styrylpyridazin-3(2H)-one derivatives as probes targeting amyloid-beta plaques in Alzheimer's disease.
    Park YD; Park JH; Hur MG; Kim SW; Min JJ; Park SH; Yoo YJ; Yoon YJ; Yang SD
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4106-10. PubMed ID: 22578456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategic Design of Amyloid-β Species Fluorescent Probes for Alzheimer's Disease.
    Su D; Diao W; Li J; Pan L; Zhang X; Wu X; Mao W
    ACS Chem Neurosci; 2022 Mar; 13(5):540-551. PubMed ID: 35132849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Iterative Design of Near-Infrared Fluorescent Probes for Early Diagnosis of Alzheimer's Disease by Targeting Aβ Oligomers.
    Liu B; Li X; Liu Z; He B; Xu H; Cao J; Zeng F; Feng H; Ren Y; Li H; Wang T; Li J; Ye Y; Zhao L; Ran C; Li Y
    J Med Chem; 2024 Jun; 67(11):9104-9123. PubMed ID: 38829030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies Targeting Soluble β-Amyloid Oligomers and their Application to Early Diagnosis of Alzheimer's Disease.
    Zeng F; Li Y; Xu Y; Yang J; Liu Z; Li X; Ren L
    Curr Alzheimer Res; 2019; 16(12):1132-1142. PubMed ID: 31670622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Development of Near-Infrared Fluorescent Probes for the
    Bajad NG; Kumar A; Singh SK
    ACS Chem Neurosci; 2023 Sep; 14(17):2955-2967. PubMed ID: 37574911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of fluorescent probes that bind and stain amyloid plaques in Alzheimer's disease.
    Jung SJ; Park SH; Lee EJ; Park JH; Kong YB; Rho JK; Hur MG; Yang SD; Park YD
    Arch Pharm Res; 2015 Nov; 38(11):1992-8. PubMed ID: 26012373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.